Dermatitis Artefacta with Proteus mirabilis Infection in Coincidence with Pyoderma Gangrenosum in Schizophrenic Patient

Main Article Content

Nurrachmat Mulianto
Bobby Febrianto
Lian Kamilah
Triasari Oktavriana


dermatitis artefacta, proteus mirabilis, pyoderma gangrenosum, schizophrenia


Dermatitis artefacta (DA) is a psychiatric disorder with secondary manifestations on the skin. One of the most common skin lesions in DA is chronic ulcer which also can be caused by pyoderma gangrenosum (PG). There are some bacteria found in chronic ulcer such as Proteus mirabilis. A forty-one years old female with chronic wounds on her chest and left leg. Based on history taking of present illness, physical examinations, laboratory tests and histopathology of the skin lesions, the patient was diagnosed with DA and PG. She was also diagnosed with schizophrenia catatonic type. Chest x-ray showed pneumonia while the swab culture showed growth of Proteus mirbabilis. She was given an oral cefadroxile 500 mg three times daily, cetirizine 10 mg once daily, wound dressing and gentamycin ointment twice daily. She also received oral risperidone 0.5 mg twice daily combined with behavioral therapy from Psychiatric Outpatientclinic. Dermatitis artefacta is a psychocutaneous disorder with uncommon morphology. The most common psychological condition related to DA is schicophrenia. There are some specific histopathology features of DA such as dominant destruction of epidermal layer, multinucleated epidermal keratinocytes or destruction of keratinocytes. Chronic ulcers in DA might be mimicking with PG, which is a chronic recidive neutrophilic dermatoses. Proteus mirabilis is one of the most common causes of urinary tract infection, meanwhile it can also cause chronic ulcers and respiratory tract infection as pneumonia.


1. Koblenzer CS. Dermatitis artefacta: Clinical features and approaches to treatment. Am J Clin Dermatol. 2000; 1(1): 47-55.

2. Mohandas P, Bewley A, Taylor R. Dermatitis artefacta and artefactual skin disease: The need for a psychodermatology multidiciplinary team to treat a difficult condition. BJD. 2013; 169: 600-6.

3. Wallach D. Pyoderma gangrenosum. In: Wallach D, Pennamen MDV, Marzano AV, editor. Neutrophilic dermatoses. Switzerland: Springer. 2018; 55-83.

4. Armbruster CE, Mobley HLT, Pearson MM. Pathogenesis of Proteus mirabilis infection. EcoSal Plus. 2018; 8(1): 1-123.

5. Krooks JA, Weatherall AG, Holland PJ. Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease. J Dermatol Treat. 2017; 29(4): 418-27.

6. Iftikhar U, Nadeem M, Aman S, Kazmi AH. Scrofuloderma: A common type of cutaneous tuberculosis. A case report. Pakistan J Dermatol. 2011: 21: 61-5.

7. Moschella SL, Davis MDP. Neutrophilic dermatoses. In: Bolognia JL, Jorizzo JL, Schaffer JV, editor. Dermatology. 3th Ed. Vol 1. St. Louis: Saunders Elsevier. 2012: 423-38.

8. Brito AC, Bittencourt MJS. Chromoblastomycosis: An etiological, epidemiological, clinical, diagnostic, and treatment update. An Bras Dermatol. 2018; 93(4): 495-506.

9. Tittelbach J, Peckruhn M, Elsner P. Histopathological patterns in dermatitis artefacta. JDDG. 2018: 559-64.

10. Rozalski A, Torzewska A, Moryl M, Kwil I, Maszewska A, Ostrowska K et al. Proteus sp-an opportunistic bacterial pathogen: classification, swarming growth, clinical significance and virulence factors. Fol Biol Oecol. 2012; 8: 1-17.

11. Okimoto N, Hayashi T, Ishiga M, Nanmba F, Kishimoto M, Yagi S et al. Clinical features of Proteus mirabilis pneumonia. J Infect Chemother. 2010; 16: 364-66.